---
figid: PMC2726733__nihms127438f2
figtitle: The antibiotic valanimycin is a naturally occurring azoxy compound isolated
  from the fermentation broth of Streptomyces viridifaciens MG456-hF10
organisms:
- NA
pmcid: PMC2726733
filename: nihms127438f2.jpg
figlink: /pmc/articles/PMC2726733/figure/F2/
number: S1
caption: The antibiotic valanimycin is a naturally occurring azoxy compound isolated
  from the fermentation broth of Streptomyces viridifaciens MG456-hF10. Enzymatic
  and genetic investigations have led to the cloning of the valanimycin gene cluster,
  which was found to contain 14 genes (). The functions of seven of these genes have
  now been established., VlmF, which is a member of the major facilitator family of
  transport proteins, confers valanimycin resistance. VlmD, VlmH, and VlmR catalyze
  the conversion of L-valine into isobutylhydroxylamine, while VlmL catalyzes the
  formation of L-seryl-tRNA from L-serine. Recently, VlmA has been shown to catalyze
  the transfer of L-serine from L-seryl-tRNA to isobutylhydroxylamine to produce O-(L-seryl)-isobutylhydroxylamine.
  Finally, VlmI has been found to be a Streptomyces antibiotic regulatory protein
  (SARP) that is a positive regulator of valanimycin biosynthesis. These studies and
  the results from precursor incorporation experiments allow formulation of the biosynthetic
  pathway for valanimycin shown in . The remaining uncertainties in the valanimycin
  pathway involve the steps required to convert O-(L-seryl)-isobutylhydroxylamine
  into valanimycin. Sequence analysis of the valanimycin biosynthetic genes provides
  relatively few clues to the nature of the later stages of the pathway. Two exceptions
  are provided by the vlmJ and vlmK genes. The translation product of vlmJ exhibits
  similarity to diacylglycerol kinases, while the translation product of vlmK exhibits
  low similarity to the MmgE/PrpD superfamily of proteins. This superfamily includes
  2-methylcitrate dehydratase, an enzyme required for propionate catabolism. In this
  communication, we provide evidence supporting the hypothesis that vlmJ and vlmK
  play a role in the final stages of valanimycin biosynthesis.
papertitle: Identification, Characterization, and Bioconversion of a New Intermediate
  in Valanimycin Biosynthesis.
reftext: Ram P. Garg, et al. J Am Chem Soc. ;131(28):9608-9609.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9583857
figid_alias: PMC2726733__S1
figtype: Scheme
organisms_ner:
- NA
redirect_from: /figures/PMC2726733__S1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2726733__nihms127438f2.html
  '@type': Dataset
  description: The antibiotic valanimycin is a naturally occurring azoxy compound
    isolated from the fermentation broth of Streptomyces viridifaciens MG456-hF10.
    Enzymatic and genetic investigations have led to the cloning of the valanimycin
    gene cluster, which was found to contain 14 genes (). The functions of seven of
    these genes have now been established., VlmF, which is a member of the major facilitator
    family of transport proteins, confers valanimycin resistance. VlmD, VlmH, and
    VlmR catalyze the conversion of L-valine into isobutylhydroxylamine, while VlmL
    catalyzes the formation of L-seryl-tRNA from L-serine. Recently, VlmA has been
    shown to catalyze the transfer of L-serine from L-seryl-tRNA to isobutylhydroxylamine
    to produce O-(L-seryl)-isobutylhydroxylamine. Finally, VlmI has been found to
    be a Streptomyces antibiotic regulatory protein (SARP) that is a positive regulator
    of valanimycin biosynthesis. These studies and the results from precursor incorporation
    experiments allow formulation of the biosynthetic pathway for valanimycin shown
    in . The remaining uncertainties in the valanimycin pathway involve the steps
    required to convert O-(L-seryl)-isobutylhydroxylamine into valanimycin. Sequence
    analysis of the valanimycin biosynthetic genes provides relatively few clues to
    the nature of the later stages of the pathway. Two exceptions are provided by
    the vlmJ and vlmK genes. The translation product of vlmJ exhibits similarity to
    diacylglycerol kinases, while the translation product of vlmK exhibits low similarity
    to the MmgE/PrpD superfamily of proteins. This superfamily includes 2-methylcitrate
    dehydratase, an enzyme required for propionate catabolism. In this communication,
    we provide evidence supporting the hypothesis that vlmJ and vlmK play a role in
    the final stages of valanimycin biosynthesis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Valanimycin
  - FAD
  - Serine
  - Valine
---
